Sirolimus conversion regimen versus continued calcineurin inhibitors in liver allograft recipients: a randomized trial.
Abdelmalek MF, Humar A, Stickel F, Andreone P, Pascher A, Barroso E, Neff GW, Ranjan D, Toselli LT, Gane EJ, Scarola J, Alberts RG, Maller ES, Lo CM; Sirolimus Liver Conversion Trial Study Group.
Abdelmalek MF, et al.
Am J Transplant. 2012 Mar;12(3):694-705. doi: 10.1111/j.1600-6143.2011.03919.x. Epub 2012 Jan 10.
Am J Transplant. 2012.
PMID: 22233522
Free article.
Clinical Trial.